Anti-diabetics Market Forecast

05 Nov 2010 • by Natalie Aster

London – “Datamonitor expects the anti-diabetics market to grow to $34.8 billion in 2019 for the seven major markets. Januvia will become the leading franchise from 2012 after patent expiry of Actos, with franchise sales reaching nearly $6 billion by 2019. Pipeline candidates will make up 30% of sales in 2019, with once-weekly GLP-1 agonists and new long-acting insulin analogs meeting success.”

The report “Anti-diabetics Market Forecast” by Datamonitor examines the future performance of leading anti-diabetic brands and the growth of generics and insulin biosimilars.

Report Details: 

Anti-diabetics Market Forecast

Publication Date: September 2010

Price:  $15,400

Format: PDF & DataPack 

Use the report to:

• Quantify the future size of the anti-diabetics market from 2010-2019 and identify opportunities for new products;
• Understand the barriers to uptake for novel anti-diabetic agents.

More information can be found in the report “Anti-diabetics Market Forecast” by Datamonitor.

To order the report or ask for sample pages contact [email protected]

Contacts

MarketPublishers, Ltd.

Mrs. Alla Martin

Tel: +357 96 030922

Fax: +44 207 900 3970

[email protected]

www.marketpublishers.com